SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001174947-24-000756
Filing Date
2024-05-28
Accepted
2024-05-28 06:32:09
Documents
5

Document Format Files

Seq Description Document Type Size
1 WRITTEN COMMUNICATIONS THIRD PARTY TENDER OFFER sctoc0524_asahikasei.htm SC TO-C 63065
2 PRESS RELEASE DATED MAY 28, 2024 sctoc0524ex99-1_asahika.htm EX-99.1 98104
3 ENGLISH VERSION OF PRESS RELEASE DATED MAY 28, 2024 sctoc0524ex99-2_asahika.htm EX-99.2 186826
4 GRAPHIC tpressrelease_logo.jpg GRAPHIC 33746
5 GRAPHIC tasahi_logo.jpg GRAPHIC 40813
  Complete submission text file 0001174947-24-000756.txt   452589
Mailing Address 1-105 KANDA JINBOCHO, CHIYODA-KU TOKYO M0 1018101
Business Address 1-105 KANDA JINBOCHO, CHIYODA-KU TOKYO M0 1018101 81 3 3296 3005
Asahi Kasei Corp (Filed by) CIK: 0001446531 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 0331
Type: SC TO-C
SIC: 8880 American Depositary Receipts
(CF Office: International Corp Fin)

Mailing Address KUNGSBRON 1, D5 STOCKHOLM V7 SE-111 22
Business Address KUNGSBRON 1, D5 STOCKHOLM V7 SE-111 22 46 8411 3005
Calliditas Therapeutics AB (Subject) CIK: 0001795579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V7 | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-91523 | Film No.: 24986212
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)